MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Pharmaceutical Economics and Policy
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,682 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,682 works in the cohort · of 4,299,418page 3 of 34

Labels cover 5 of 1,682 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,682 of 1,682 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
The Morally Uncomfortable Global Drug Gap
Jillian Clare Cohen-Kohler
2007· article· en· Clinical Pharmacology & Therapeutics· Economics, Econometrics and Finance
distilled prediction:candidate · insufficient_payloadconsensus · none
44
citations
affunlabeled
The failure of torcetrapib: what have we learned?
Tisha Joy, Robert A. Hegele
2008· letter· en· British Journal of Pharmacology· Economics, Econometrics and Finance
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · none
43
citations
affvenueunlabeled
New approaches to rewarding pharmaceutical innovation
Paul Grootendorst, Aidan Hollis, David K. Levine, Thomas Pogge, A.M. Edwards
2010· article· en· Canadian Medical Association Journal· Economics, Econometrics and Finance
distilled prediction:candidate · insufficient_payloadconsensus · insufficient_payload
42
citations
aboutno affunlabeled
Merck's Recall of Rofecoxib — A Strategic Perspective
Felix Oberholzer‐Gee, S. Noorein Inamdar
2004· article· en· New England Journal of Medicine· Economics, Econometrics and Finance
distilled prediction:candidate · noneconsensus · none
40
citations
affaboutunlabeled
Lowering Generic Drug Prices
Aslam H. Anis, Daphne Guh, John Woolcott
2003· article· en· Medical Care· Economics, Econometrics and Finance
distilled prediction:candidate · insufficient_payloadconsensus · insufficient_payload
39
citations
affno abstractunlabeled
Polypills
Mark D. Huffman, Salim Yusuf
2014· article· en· Journal of the American College of Cardiology· Economics, Econometrics and Finance
distilled prediction:candidate · noneconsensus · none
37
citations
affaboutno abstractunlabeled
Drug shortages in Canadian anesthesia: a national survey
Richard Hall, Gregory L. Bryson, Gordon Flowerdew, David Neilipovitz, Agnieszka Grabowski-Comeau, Alexis F. Turgeon
2013· article· en· Canadian Journal of Anesthesia/Journal canadien d anesthésie· Economics, Econometrics and Finance
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
36
citations

How this was built: Screen · Findings · About